Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zibotentan in Scleroderma Renal Disease (ZEBRA)
NCT02047708Phase 2Completed
- Sponsor
- University College London
- Start
- Oct 2014
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zibotentan in chronic kidney disease (CKD), scleroderma renal crisis (SRC), sponsored by University College London. Started Oct 2014; status: completed.
02
Drugs
zibotentan
03
Conditions
chronic kidney disease (CKD)scleroderma renal crisis (SRC)
Beyond the preview
Go deeper on NCT02047708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047708.